Give more people weight loss jabs on the NHS, say MPs
Current plans for 6% of eligible patients to get Mounjaro by 2028 unambitious, say MPs.
BBC News reports: Current plans for 6% of eligible patients to get Mounjaro by 2028 unambitious, say MPs.
This health story centres on the United Kingdom. Names and organisations mentioned in the coverage include MPs, NHS and Mounjaro.
Why it matters
Health developments can affect patients, healthcare providers and public-health planning.
Key details
- Location
- United Kingdom · Europe
- Reported by
- BBC News
- First reported
- Key names
- MPs, NHS, Mounjaro
- Section
- Health
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at BBC NewsSpotted an error? Request a correction · How this summary was produced
Related Stories
Child health in England at risk from sharp rise in NHS waiting times, report says
CQC research finds long delays are making conditions harder to treat and highlights regional disparities in care Thousands of children in England…
You be the chancellor: play our budget game to see if you can balance the books
See if you can do a better job than John Healey at creating a budget that keeps MPs and the bond markets onside On 28 October, John Healey will…
Aneurin Bevan’s personal security file was ‘remarkably tame’ – National Archives
Some in UK’s security services questioned why Welsh Labour firebrand was of interest Aneurin “Nye” Bevan, the Welsh Labour firebrand who spearheaded…
Woman told she had cancer by NHS worker who inappropriately accessed her records
Pippa Boardman said she lost her dignity through data breach at Royal Cornwall hospital by man she barely knew A woman was told she had cancer by a…
I thought I was dying but it was health anxiety - here's how to recognise the signs
Hollie Sharman shares her experience of health anxiety and a doctor advises on how to manage symptoms.
Haematology centre for cancer patients at risk over 'disgraceful' funds move
The Department of Health has decided to take back £1.5m from the project, Belfast Trust officials have told a Stormont committee.
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to…
Why measles outbreak in Pennsylvania poses risks beyond US borders
The United States is facing its largest outbreak of measles since the virus was declared eliminated in 2000.